J&J's Janssen Gets CHMP Positive Opinion for Stelara in Ulcerative Colitis

Date : 07/26/2019 @ 1:09PM
Source : Dow Jones News
Stock : Johnson and Johnson (JNJ)
Quote : 132.84  0.0 (0.00%) @ 2:28PM

J&J's Janssen Gets CHMP Positive Opinion for Stelara in Ulcerative Colitis

Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart

3 Months : From Jul 2019 to Oct 2019

Click Here for more Johnson and Johnson Charts.

By Colin Kellaher


Johnson & Johnson's (JNJ) Janssen Pharmaceutical Cos. unit on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization of Stelara in adults with the inflammatory disease ulcerative colitis.

Janssen said the CHMP positive opinion covers the use of use of Stelara for the treatment of adults with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies.

The company said there is currently no cure for ulcerative colitis, a chronic immune-mediated inflammatory disease of the large intestine that affects 2.6 million people in Europe.

Janssen said it expects a final decision from the European Commission later this year. The commission generally follows the CHMP's recommendations.


Write to Colin Kellaher at colin.kellaher@wsj.com


(END) Dow Jones Newswires

July 26, 2019 07:54 ET (11:54 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest JNJ Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.